The “rare patient” Julia del Amo ISCIII, Madrid, Spain.

Slides:



Advertisements
Similar presentations
TB and HIV: Tightly Linked… and Why We Should Care.
Advertisements

Towards an AIDS-Free Generation Women & Girls and HIV in PEPFAR
Modelling HIV/AIDS in Southern Africa Centre for Actuarial Research (CARe) A Research Unit of the University of Cape Town.
Funding of Cohort Studies Diana Finzi, Ph.D. Chief, Pathogenesis and Basic Research Branch Division of AIDS National Institutes of Health Bethesda, Maryland,
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
1 HIV/AIDS, INFANT FEEDING, AND HUMAN RIGHTS George Kent University of Hawai’i.
Thailand’s HIV and AIDS STRATEGY
Know Your epidemic: The value of population-based household surveys Eva Kiwango Senior Strategic Information Advisor United Nations Joint Programme on.
INTEGRATING PROGRAMMING TO ADDRESS GENDER-BASED VIOLENCE AND ENGAGE MEN AND BOYS TO CHALLENGE GENDER INEQUALITY IN NATIONAL AIDS STRATEGIES AND PLANS
00003-E-1 – December 2004 Global summary of the HIV and AIDS epidemic, December 2004 The ranges around the estimates in this table define the boundaries.
00002-E-1 – 1 December 2003 Global summary of the HIV/AIDS epidemic, December 2003 The ranges around the estimates in this table define the boundaries.
2,100,000 Number of pregnant women with HIV/AIDS 200,000Number of pregnant women receiving PMTCT 630,000Number of MTCT new infections 2,000,000Number of.
HIV Early Treatment Project Groups 1 and 2 n Among HIV-infected participants in sub-Saharan Africa, does initiation of antiretroviral treatment (ART) at.
Global Awareness Program Women’s Health. What sets women’s health apart from men’s? Two big themes: 1)Women generally need more health care than men because.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Millennium development goal: Combating the spread of HIV/Aids.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
HIV and Indigenous Peoples in Aotearoa, Australia and Canada Clive Aspin.
Creating an AIDS-Free Generation The beginning of the end of AIDS Center for Strategic & International Studies Washington, DC March 22, 2012 Thomas R.
Chapter 1: An Overview of the HIV/AIDS Epidemic Module 1, Chapter 1.
____________________________________ Commonwealth Foundation Partner’s Forum 9 th Commonwealth Women’s Affairs Ministers’ Meeting Gender issues in the.
Clinical Care of HIV, AIDS and Opportunistic Infections
LESLEY DOYAL UNIVERSITY OF BRISTOL Exploring inequities in health BETWEEN women.
OVERVIEW OF THE HIV/AIDS EPIDEMIC Marie Laga
Introduction About HIV/AIDS in Hangzhou Hangzhou Center For Disease Control And Prevention — by Zhao Gang — by Zhao Gang.
The mysterious emergence of HIV/AIDS Malthus’s ghost: is this a XXth century ‘positive’ check? Where does it come from? Runs counter to the idea that health.
Sexual transmission of HIV amongst migrant populations in Europe: managing change in surveillance, interventions and prevention V.Delpech and Teymur Noori.
AIDS in Sub Saharan Africa AIDS – a virus with no known cure first identified in the Belgian Congo in It’s now a global epidemic, and poverty and.
Topical Microbicides Antiviral Drugs Advisory Committee August 20, 2003.
00003-E-1 – December 2005 Global summary of the HIV and AIDS epidemic, December 2005 The ranges around the estimates in this table define the boundaries.
Global HIV prevalence in adults, 1985 UNAIDS/WHO, 2006.
P1 Virology, Pathogenesis And Treatment Of HIV Infection.
Millennium Development Goals Carla AbouZahr Coordinator, Statistics, Monitoring and Analysis Department of Health Statistics and Informatics World Health.
Salim S. Abdool Karim, MBChB, PhD and Quarraisha Abdool Karim, PhD.
Influences on health and status and the millennium development goals.
July 2015 Core Epidemiology Slides.
Reproductive Health Class #1. What Is Reproductive Health ?
Clinic-based Translational Research Cohort/ Clinical Trial Immunology Core Lab (Sinclair) Basic Immunology Lab (McCune) Virology Core Lab (Liegler) Basic.
00002-E-1 – 1 December 2001 Global summary of the HIV/AIDS epidemic, December 2001 Number of people living with HIV/AIDS Total40 million Adults37.2 million.
1 Total 33.2 million [30.6 – 36.1 million] Adults 30.8 million [28.2 – 33.6 million] Women 15.4 million [13.9 – 16.6 million] Children under 15 years 2.5.
00002-E-1 – 1 December 2002 Global summary of the HIV/AIDS epidemic, December 2002 Number of people living with HIV/AIDS Total42 million Adults38.6 million.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Mongolia Last updated: December 2014.
Temporal Trends in Clinical Characteristics and Outcome of Patient’s enrolled in ART program, in Dar es Salaam, Tanzania. Retroviruses and Novel.
Estimating the Impact and Needs for Children and PMTCT Making sense: Understanding the numbers: from HIV surveillance to national and global HIV burden.
Africans and HIV in the UK: an epidemiological perspective May 2006 Valerie Delpech On behalf of the HIV Reporting Section with special thanks to Julia.
1 July 2008 e Global summary of the AIDS epidemic, December 2007 Total33 million [30 – 36 million] Adults30.8 million [28.2 – 34.0 million] Women15.5 million.
00002-E-1 – 1 December 2001 THE HIV/AIDS PANDEMIC Focus on Africa By Dr. David Elkins HIV/AIDS Prevention and Care Project Nairobi, Kenya September 2002.
1 Module 1: [Basic] Unit 1: [HIV Epidemics and Key Populations] Lesson 2: [Levels of HIV Epidemic in the World] “Community-Based HIV Surveillance” Online.
Global Impact of HIV/AIDS Deborah Lewinsohn, M.D. Infectious Diseases, Pediatrics Vaccine and Gene Therapy Institute Oregon Health & Science University.
Contents - HIV global slides
BUILDING INTEGRATED HEALTH SERVICE DELIVERY NETWORKS
Access and response to ART among migrants
Fundamentals of Epidemiology
Number of people receiving antiretroviral therapy in
WHO strategy on HIV/AIDS “Getting to Zero”
The country with the largest population in Africa is
Funding: Red de Investigación de SIDA (RD12/0017)
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
World Health Organization
Gender Gender refers to the socially constructed characteristics of women and men – such as norms, roles and relationships of and between groups of women.
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
WHO HIV update July 2018 Global epidemic Global progress and cascade
Contents - HIV global slides
Migrants Dr Julia del Amo National Center for Epidemiology
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Contents - HIV global slides
The country with the largest population in Africa is
Surveillance of Tuberculosis
Collaborative TB/HIV activities in European Region
Contents - HIV global slides
Presentation transcript:

The “rare patient” Julia del Amo ISCIII, Madrid, Spain

The Translational Power of Collaboration: Harnessing Large Datasets to Understand the HIV/AIDS Epidemic and to Optimize Care and Treatment Rare patients from cohort studies can inform public health policy

Definition of “rare” from the Oxford dictionary (of an event, situation, or condition) not occurring very often (of a thing) not found in large numbers and so of interest or value unusually good or remarkable

Synonyms and antonyms of rare Uncommon infrequent Scarce extraordinary – common – frequent – abundant – ordinary

To find uncommon events you need: To contextualize them to value their “uniqueness” To find the rare ones within large numbers of common events

What is the role of Extremely Large Datasets in HIV/AIDS and Global Cohort Collaborations regarding “rare patients” ?

International cohort collaborations allow identifying meaningful numbers of "rare subjects"

Those with uncommon and/or remarkable features Who are rare subjects in HIV/AIDS ? Rare “Exposures” and “Outcomes” Outcomes Exposures

Clinical presentations Response to treatment Socio-demographic characteristics Disease progression patterns Biological traits

Socio-demographic characteristics Women in Western epidemics Children in Western epidemics Migrants from specific origins Distinct ethnic minorities People over 70 years “Rare exposures”

Socio-demographic characteristics Women in Western epidemics Children in Western epidemics Migrants from specific origins Distinct ethnic minorities People over 70 years “Rare exposures” Depends on the setting

“Rare events”

Long-term non-progressors and elite controlers Rapid and very rapid disease progression Viraemic non progressor Seroconverters with narrow windows - primoinfected During pregnancy HIV-2

Long-term non-progressors and elite controlers Rapid and very rapid disease progression Viraemic non progressor Seroconverters with narrow windows - primoinfected During pregnancy HIV-2 Understanding Pathogenesis

Vertical transmission despite PMTCT Treatment in infants Presenters with < 50 cells/mm 3 ART response in non-B HIV-1 subtypes Uncommon adverse effects of ART Cause-specific mortality in specific groups Women Migrants Ethnic minorities

Vertical transmission despite PMTCT Treatment in infants Presenters with < 50 cells/mm 3 ART response in non-B HIV-1 subtypes Uncommon adverse effects of ART Cause-specific mortality in specific groups Women Migrants Ethnic minorities Policy Implications

Except for some groups such as migrants from Sub-Saharan Africa, the proportion of women in the HIV epidemic in Europe has been < 25% In Sub-Saharan African cohorts, women account for > 50% of the subjects What is rare in a setting may be common in another

Men Women Deaths Deaths without AIDS

WE NAME SSA LA Asia Deaths

Three axes- gender, ethnicity and social class – conform social health inequalities

Gender, ethnicity and social class should be viewed as EFFECT MODIFIERS rather than confounders requiring stratified analyses

Three axes- gender, ethnicity and social class – conform social health inequalities Gender, ethnicity and social class should be viewed as EFFECT MODIFIERS rather than confounders requiring stratified analyses  Incorrect assumption that unmeasured confounders are equally distributed within these three axes

Study key outcomes by geographical origin and sex in COHERE: Appropriateness of the timing of cART initiation and treatment interruptions cART Virological and immunological responses All-cause and cause-specific mortality

High numbers High power Low data quality Misclassification Non-differential

High numbers High power Low data quality Misclassification Non-differential

Strategic questions on rare subjects need to be formulated within large datasets

using standardized definitions to provide the adequate statistical power for its translation into public health policy quality control procedures Strategic questions on rare subjects need to be formulated within large datasets

Founding networks

Thank you for your attention